Momenta Phamaceuticals, Inc. (MNTA) Misses Q3 EPS by 12c

November 7, 2011 8:52 AM EST
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q3 EPS of $1.18, $0.12 worse than the analyst estimate of $1.30. Revenue for the quarter came in at $87.9 million versus the consensus estimate of $90.92 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings